Future Monetary Costs of Dementia in the United States Under Alternative Dementia Prevalence Scenarios

Population aging will likely lead to increases in health care spending and the ability of governments to support entitlement programs such as Medicare and Medicaid. Dementia is a chronic condition that is especially pertinent because of its strong association with old age and because care for dementia is labor intensive and expensive. Indeed, prior research has found that if current dementia prevalence rates persist, population aging will generate very large increases in health care spending for dementia. In this study we considered two alternative assumptions or scenarios about future prevalence. The first adjusts the prevalence projections using recent research that suggests dementia prevalence may be declining. The second uses growth hypertension, obesity and diabetes, and the relationship between dementia and these conditions to adjust future prevalence rates. We find under the first scenario that if the rates of decline in age-specific dementia rates persist, future costs will be much less than previous estimates, about 40 % lower. Under the second scenario, the growth in those conditions makes only small differences in costs.

[1]  C. Brayne,et al.  Prevalence Studies of Dementia in Mainland China, Hong Kong and Taiwan: A Systematic Review and Meta-Analysis , 2013, Alzheimer's & Dementia.

[2]  J. Karlawish,et al.  Trends in the prevalence and mortality of cognitive impairment in the United States: Is there evidence of a compression of cognitive morbidity? , 2008, Alzheimer's & Dementia.

[3]  S. Leurgans,et al.  Sources of variability in estimates of the prevalence of Alzheimer’s disease in the United States , 2011, Alzheimer's & Dementia.

[4]  K. Yaffe,et al.  The projected effect of risk factor reduction on Alzheimer's disease prevalence , 2011, The Lancet Neurology.

[5]  Paco Martorell,et al.  Monetary costs of dementia in the United States. , 2013, The New England journal of medicine.

[6]  Steven G Heeringa,et al.  Prevalence of Cognitive Impairment without Dementia in the United States , 2008, Annals of Internal Medicine.

[7]  Kristine Yaffe,et al.  New insights into the dementia epidemic. , 2013, The New England journal of medicine.

[8]  J. Bond,et al.  A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: results of the Cognitive Function and Ageing Study I and II , 2013, The Lancet.

[9]  K. Langa,et al.  Prevalence of Dementia in the United States: The Aging, Demographics, and Memory Study , 2007, Neuroepidemiology.

[10]  Josip Car,et al.  Epidemiology of Alzheimer ' s disease and other forms of dementia in China , 1990-2010 , 2013 .

[11]  R. Petersen,et al.  Trends in the incidence and prevalence of Alzheimer’s disease, dementia, and cognitive impairment in the United States , 2011, Alzheimer's & Dementia.

[12]  John Bond,et al.  The worldwide economic impact of dementia 2010 , 2013, Alzheimer's & Dementia.

[13]  Y. Stern Cognitive reserve in ageing and Alzheimer's disease , 2012, The Lancet Neurology.

[14]  Anthony F Jorm A short form of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): development and cross-validation , 1994, Psychological Medicine.

[15]  H. Brodaty,et al.  ALZHEIMER'S DISEASE INTERNATIONAL , 1997, International journal of geriatric psychiatry.

[16]  S. Ukraintseva,et al.  Declining prevalence of dementia in the U.S. elderly population. , 2005, Advances in gerontology = Uspekhi gerontologii.

[17]  Benjamin F. J. Verhaaren,et al.  Is dementia incidence declining? , 2012, Neurology.